BioComp Pharma Inc.
6 drugs in NADAC|6 Generic,0 Brand
BioComp Pharma Inc. lists 6 NDCs in the CMS NADAC file (6 generic, 0 brand), at an average NADAC of $1.04 per unit, with a week-over-week move of +1.0% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
6
6G / 0B
Avg Price / Unit
$1.0407
$0.17 – $2.35
Avg 7d Change
+1.04%
Across 5 drugs with changes
7d Activity
of 6 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
tinidazole market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
Nitroimidazole Antimicrobial therapeutic class
Review the broader class where BioComp Pharma Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does BioComp Pharma Inc. make?
BioComp Pharma Inc. lists 6 NDCs in the CMS NADAC file — 6 generic and 0 brand products.
What is the average price of BioComp Pharma Inc. drugs?
The average NADAC across BioComp Pharma Inc.'s portfolio is $1.0407 per unit, ranging from $0.1742 to $2.3543.
What types of drugs does BioComp Pharma Inc. make?
BioComp Pharma Inc. makes drugs across 5 FDA pharmacologic classes. The most common by NDC count are Nitroimidazole Antimicrobial (2), Anti-coagulant (2), Calculi Dissolution Agent (2), Corticosteroid (1), Histamine-1 Receptor Antagonist (1).
Has BioComp Pharma Inc. had any drug recalls?
No FDA enforcement recalls are matched to BioComp Pharma Inc. in the openFDA feed.
How has BioComp Pharma Inc.'s pricing changed recently?
Over the past 7 days, 2 BioComp Pharma Inc. products rose and 3 fell, with a portfolio-wide average change of +1.0%.
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TINIDAZOLE 500 MG TABLET tinidazole | $2.3543 per EA | +7.08% |
TINIDAZOLE 500 MG TABLET tinidazole | $2.3543 per EA | +7.08% |
PREDNISOLONE SOD PH 25 MG/5 ML Prednisolone Sodium Phosphate | $0.7881 per ML | — |
CARBINOXAMINE MALEATE 4 MG TAB Carbinoxamine Maleate | $0.3981 per EA | -2.91% |
POTASSIUM CITRATE ER 10 MEQ TB potassium citrate | $0.1752 per EA | -2.59% |
POTASSIUM CITRATE ER 15 MEQ TB potassium citrate | $0.1742 per EA | -3.45% |